InspireMD to Announce Second Quarter 2025 Financial Results
InspireMD (Nasdaq: NSPR), developer of the CGuard庐 Prime carotid stent system, will release its Q2 2025 financial results on Tuesday, August 5, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss financial results and recent highlights.
Investors can access the earnings call by dialing 1-800-579-2543 (domestic) or 1-785-424-1789 (international). A webcast will be available on InspireMD's website, and a replay will be archived for later viewing.
InspireMD (Nasdaq: NSPR), sviluppatore del sistema di stent carotideo CGuard庐 Prime, annuncer脿 i risultati finanziari del secondo trimestre 2025 marted矛 5 agosto 2025. La societ脿 terr脿 una conference call e una webcast alle 8:30 del mattino, ora della costa orientale per discutere i risultati finanziari e gli ultimi aggiornamenti.
Gli investitori potranno partecipare alla chiamata componendo il numero 1-800-579-2543 (nazionale) o 1-785-424-1789 (internazionale). La webcast sar脿 disponibile sul sito web di InspireMD e la registrazione sar脿 archiviata per la visione successiva.
InspireMD (Nasdaq: NSPR), desarrollador del sistema de stent carot铆deo CGuard庐 Prime, publicar谩 sus resultados financieros del segundo trimestre de 2025 el martes 5 de agosto de 2025. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en vivo a las 8:30 a.m., hora del Este para discutir los resultados financieros y las novedades recientes.
Los inversores podr谩n acceder a la llamada de resultados marcando el 1-800-579-2543 (nacional) o el 1-785-424-1789 (internacional). La transmisi贸n en vivo estar谩 disponible en el sitio web de InspireMD y se archivar谩 una repetici贸n para su visualizaci贸n posterior.
InspireMD (雮橃姢雼�: NSPR)電� CGuard庐 Prime 瓴诫彊毵� 鞀ろ厫韸� 鞁滌姢韰� 臧滊皽鞐呾泊搿滌劀, 2025雲� 8鞗� 5鞚� 頇旍殧鞚� 2攵勱赴 2025雲� 鞛鞁れ爜鞚� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 霃欕秬 響滌鞁� 鞓れ爠 8鞁� 30攵�鞐� 鞛鞁れ爜 氚� 斓滉芳 欤检殧 靷暛鞚� 雲检潣頃橁赴 鞙勴暅 旎嵓霟办姢 旖� 氚� 鞗轨簮鞀ろ姼毳� 歆勴枆頃╇媹雼�.
韴瀽鞛愲摛鞚� 甑偞 鞝勴檾氩堩樃 1-800-579-2543 霕愲姅 甑牅 鞝勴檾氩堩樃 1-785-424-1789搿� 鞝勴檾頃橃棳 鞁れ爜 氚滍憸 韱淀檾鞐� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼電� InspireMD 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅橂┌, 雼れ嫓氤搓赴鞖� 鞎勳勾鞚措笇霃� 毵堧牗霅╇媹雼�.
InspireMD (Nasdaq : NSPR), d茅veloppeur du syst猫me de stent carotidien CGuard庐 Prime, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 le mardi 5 ao没t 2025. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une webdiffusion 脿 8h30, heure de l'Est pour discuter des r茅sultats financiers et des faits marquants r茅cents.
Les investisseurs peuvent acc茅der 脿 la conf茅rence t茅l茅phonique en composant le 1-800-579-2543 (num茅ro national) ou le 1-785-424-1789 (num茅ro international). Une webdiffusion sera disponible sur le site web d'InspireMD, et un replay sera archiv茅 pour une consultation ult茅rieure.
InspireMD (Nasdaq: NSPR), Entwickler des CGuard庐 Prime Carotis-Stentsystems, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 am Dienstag, den 5. August 2025 ver枚ffentlichen. Das Unternehmen veranstaltet um 8:30 Uhr Eastern Time eine Telefonkonferenz und ein Webcast, um die Finanzergebnisse und aktuelle Highlights zu besprechen.
Investoren k枚nnen die Gewinnkonferenz unter der Nummer 1-800-579-2543 (national) oder 1-785-424-1789 (international) erreichen. Das Webcast wird auf der Website von InspireMD verf眉gbar sein, und eine Aufzeichnung wird f眉r eine sp盲tere Ansicht archiviert.
- None.
- None.
MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard庐 Prime carotid stent system for the prevention of stroke, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD鈥檚 website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD鈥檚 website.
Webcast:
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet鈩� mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD鈥檚 common stock is quoted on Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit .
Investor Contact:
Webb Campbell
Gilmartin Group LLC
[email protected]
[email protected]
FAQ
When will InspireMD (NSPR) report Q2 2025 earnings?
How can I listen to InspireMD's Q2 2025 earnings call?
What does InspireMD (NSPR) manufacture?
Will there be a replay of InspireMD's Q2 2025 earnings call?
